
Fertility Supplements Market Size, Share & Trends Analysis Report By Ingredient (Natural, Synthetic/Blend), By Product (Capsules, Tablets, Soft Gels), By End-use, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030
Description
Fertility Supplements Market Size, Share & Trends Analysis Report By Ingredient (Natural, Synthetic/Blend), By Product (Capsules, Tablets, Soft Gels), By End-use, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030
Fertility Supplements Market Growth & Trends
The global fertility supplements market size is predicted to reach USD 3.52 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 7.9% from 2022 to 2030. The decline in fertility rates caused by increased consumption of cigarettes, alcohol, and caffeine is expected to fuel demand for fertility supplements in the coming years.
Rising demand for herbal fertility supplements owing to their natural ingredients is expected to drive the market. Consumers are seeking ingredients such as primrose oil, red clover, and grape seed extracts in products that are highly effective and have low side effects. In order to meet consumer demand all over the world, manufacturers are focusing on offering a combination of natural and synthetic ingredients. This trend is likely to continue over the forecast period and propel the market growth.
Growing consumer awareness regarding the nutritional value and health advantages of consuming dietary supplements is leading to a rise in the demand for over-the-counter (OTC) fertility supplement products. Therefore, the market is anticipated to witness substantial growth in emerging economies. Demand for fertility supplements is also anticipated to increase over the forecast period due to self-medication, cost efficiency, and convenience of direct purchase.
Male infertility is mostly known to be caused by low sperm counts or lower sperm motility, which may be caused by hormonal imbalances. The pituitary gland and hypothalamus must function properly for both men and women to avoid hormonal imbalance and to be fertile. Increased alcohol and drug use, higher levels of stress, obesity, environmental factors, and frequent smoking are among the main causes of the rise in infertility rates, which will fuel the demand for fertility supplements.
Numerous government initiatives are planned to raise public awareness regarding fertility supplements and advance research and development, which has aided decision-makers in selecting supplements while taking their prior illness into account. For instance, U.S. Preventive Services Tasks, the Institute of Medicine, and the Centers for Disease Control and Prevention recommend all women in reproductive age consume folic acid to prevent birth defects such as Neural Tube Defects (NTD). The market for fertility supplements is expected to expand as a result of the current focus on sexual well-being and increased consumer interest in fertility supplements.
Government initiatives such as one child per couple, which involved forced sterilizations or abortions, reduced women's fertility. However, it is anticipated that the elimination of the one- or two-child per couple policies and significant changes to family planning laws will positively impact fertility rates. This element is predicted to hamper market expansion in China.
Fertility Supplements Market Report Highlights
Fertility Supplements Market Growth & Trends
The global fertility supplements market size is predicted to reach USD 3.52 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 7.9% from 2022 to 2030. The decline in fertility rates caused by increased consumption of cigarettes, alcohol, and caffeine is expected to fuel demand for fertility supplements in the coming years.
Rising demand for herbal fertility supplements owing to their natural ingredients is expected to drive the market. Consumers are seeking ingredients such as primrose oil, red clover, and grape seed extracts in products that are highly effective and have low side effects. In order to meet consumer demand all over the world, manufacturers are focusing on offering a combination of natural and synthetic ingredients. This trend is likely to continue over the forecast period and propel the market growth.
Growing consumer awareness regarding the nutritional value and health advantages of consuming dietary supplements is leading to a rise in the demand for over-the-counter (OTC) fertility supplement products. Therefore, the market is anticipated to witness substantial growth in emerging economies. Demand for fertility supplements is also anticipated to increase over the forecast period due to self-medication, cost efficiency, and convenience of direct purchase.
Male infertility is mostly known to be caused by low sperm counts or lower sperm motility, which may be caused by hormonal imbalances. The pituitary gland and hypothalamus must function properly for both men and women to avoid hormonal imbalance and to be fertile. Increased alcohol and drug use, higher levels of stress, obesity, environmental factors, and frequent smoking are among the main causes of the rise in infertility rates, which will fuel the demand for fertility supplements.
Numerous government initiatives are planned to raise public awareness regarding fertility supplements and advance research and development, which has aided decision-makers in selecting supplements while taking their prior illness into account. For instance, U.S. Preventive Services Tasks, the Institute of Medicine, and the Centers for Disease Control and Prevention recommend all women in reproductive age consume folic acid to prevent birth defects such as Neural Tube Defects (NTD). The market for fertility supplements is expected to expand as a result of the current focus on sexual well-being and increased consumer interest in fertility supplements.
Government initiatives such as one child per couple, which involved forced sterilizations or abortions, reduced women's fertility. However, it is anticipated that the elimination of the one- or two-child per couple policies and significant changes to family planning laws will positively impact fertility rates. This element is predicted to hamper market expansion in China.
Fertility Supplements Market Report Highlights
- By ingredient, the natural segment is predicted to expand at the fastest CAGR of 10.0% in the forecast period owing to changing consumer preferences for using products that contain herbal and organic ingredients rather than synthetic ingredients
- By product, capsules and tablets held a sizeable revenue share in 2021 on account of ease of consumption and convenience for consumers
- By distribution channel, the over-the-counter (OTC) segment led the market with a revenue share of over 75.0% in 2021 owing to the accessibility and convenient purchasing of such products
- Asia Pacific is anticipated to witness the fastest growth in the forecast period owing to rising consumption of supplements and growing retail chains in India, Japan, and China
- The market for fertility supplements is highly competitive. A number of strategic initiatives, such as mergers and acquisitions, product innovation, and portfolio expansion, have been favored by the dominant market players
Table of Contents
150 Pages
- Chapter 1 Methodology and Scope
- 1.1 Information Procurement
- 1.1.1 Purchased Database
- 1.1.2 GVR’s Internal Database
- 1.1.3 Secondary Sources
- 1.1.4 Third Party Perspective
- 1.1.5 Primary Research
- 1.2 Information Analysis & Data Analysis Models
- 1.3 List to Data Sources
- Chapter 2 Executive Summary
- 2.1 Market Insights
- 2.2 Segmental Insights
- 2.3 Competitive Insights
- Chapter 3 Market Variables, Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent market outlook: Dietary supplements market
- 3.1.2 Related market outlook: Infertility treatment market
- 3.2 Penetration & Growth Prospect Mapping
- 3.3 Value Chain Analysis
- 3.3.1 Manufacturing trends
- 3.3.2 Technology trends
- 3.3.3 Cost structure analysis
- 3.3.4 Sales channel analysis
- 3.3.5 Vendor selection criteria
- 3.3.6 Profit margin analysis
- 3.4 Raw Material Trends & Analysis
- 3.5 Regulatory Framework
- 3.5.1 Standards & Compliances
- 3.5.2 Product classification codes
- 3.5.3 Safety
- 3.6 Market Dynamics
- 3.6.1 Market Driver Analysis
- 3.6.2 Market Restraint Analysis
- 3.6.3 Industry Challenges
- 3.7 Business Environment Analysis
- 3.7.1 Porter’s Analysis
- 3.7.1.1 Threat of new entrants
- 3.7.1.2 Bargaining power of buyers
- 3.7.1.3 Bargaining power of Suppliers
- 3.7.1.4 Threat of substitutes
- 3.7.1.5 Competitive rivalry
- 3.7.2 PESTEL Analysis
- 3.7.3 Major Deals & Strategic Alliances Analysis
- 3.7.3.1 Licensing & Partnership
- 3.7.3.2 Capacity Expansion
- 3.7.3.3 Product Development
- 3.8 Market Entry Strategies
- 3.9 Key Product/Brand Analysis
- 3.9.1 List of clinical trials on major brands & ingredients
- 3.9.1.1 Clinical trials on key brands
- 3.9.1.2 Clinical trials on synthetic ingredients
- 3.9.1.3 Studies on natural ingredients
- 3.9.2 Impact of clinical trials on fertility supplements market
- Chapter 4 Fertility Supplements Market: Ingredient Market Estimates & Trend Analysis
- 4.1 Definitions & Scope
- 4.2 Ingredient Movement Analysis & Market Shares, 2021 & 2030
- 4.3 Natural Ingredients
- 4.3.1 Natural ingredients market estimates and forecasts, 2017 - 2030 (USD Million)
- 4.4 Synthetic/Blend of Synthetic & Natural Ingredients
- 4.4.1 Synthetic/blend of synthetic & natural ingredients market estimates and forecasts, 2017 - 2030 (USD Million)
- Chapter 5 Fertility Supplements Market: Product Market Estimates & Trend Analysis
- 5.1 Definitions & Scope
- 5.2 Product Movement Analysis & Market Shares, 2021 & 2030
- 5.3 Capsules
- 5.3.1 Fertility supplement capsules market estimates and forecasts, 2017 - 2030 (USD Million)
- 5.4 Tablets
- 5.4.1 Fertility supplement tablets market estimates and forecasts, 2017 - 2030 (USD Million)
- 5.5 Soft Gels
- 5.5.1 Fertility supplement soft gels market estimates and forecasts, 2017 - 2030 (USD Million)
- 5.6 Powder
- 5.6.1 Fertility supplement powder market estimates and forecasts, 2017 - 2030 (USD Million)
- 5.7 Liquids
- 5.7.1 Fertility supplement liquids market estimates and forecasts, 2017 - 2030 (USD Million)
- Chapter 6 Fertility Supplements Market: End-Use Market Estimates & Trend Analysis
- 6.1 Definitions & Scope
- 6.2 End-Use Movement Analysis & Market Shares, 2021 & 2030
- 6.3 Men
- 6.3.1 Fertility supplements market estimates and forecasts for men, 2017 - 2030 (USD Million)
- 6.4 Women
- 6.4.1 Fertility supplements market estimates and forecasts for women, 2017 - 2030 (USD Million)
- Chapter 7 Fertility Supplements Market: Distribution Channel Market Estimates & Trend Analysis
- 7.1 Definitions & Scope
- 7.2 Distribution Channel Movement Analysis & Market Shares, 2021 & 2030
- 7.3 OTC
- 7.3.1 OTC fertility supplements market estimates and forecasts, 2017 - 2030 (USD Million)
- 7.4 Prescribed
- 7.4.1 Prescribed fertility supplements market estimates and forecasts, 2017 - 2030 (USD Million)
- Chapter 8 Fertility Supplements Market: Regional Estimates & Trend Analysis
- 8.1 Regional Market Snapshot
- 8.2 SWOT Analysis, by Region
- 8.2.1 North America
- 8.2.2 Europe
- 8.2.3 Asia Pacific
- 8.2.4 Central & South America
- 8.2.5 The Middle East & Africa
- 8.3 Regional movement & market share analysis, 2021 & 2030
- 8.4 North America
- 8.4.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.4.2 Market estimates and forecasts, by ingredient, 2017 - 2030 (USD Million)
- 8.4.3 Market estimates and forecasts, by product, 2017 - 2030 (USD Million)
- 8.4.4 Market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- 8.4.5 Market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- 8.4.6 U.S.
- 8.4.6.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.4.6.2 Market estimates and forecasts, by ingredient, 2017 - 2030 (USD Million)
- 8.4.6.3 Market estimates and forecasts, by product, 2017 - 2030 (USD Million)
- 8.4.6.4 Market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- 8.4.6.5 Market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- 8.4.7 Canada
- 8.4.7.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.4.7.2 Market estimates and forecasts, by ingredient, 2017 - 2030 (USD Million)
- 8.4.7.3 Market estimates and forecasts, by product, 2017 - 2030 (USD Million)
- 8.4.7.4 Market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- 8.4.7.5 Market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- 8.4.8 Mexico
- 8.4.8.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.4.8.2 Market estimates and forecasts, by ingredient, 2017 - 2030 (USD Million)
- 8.4.8.3 Market estimates and forecasts, by product, 2017 - 2030 (USD Million)
- 8.4.8.4 Market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- 8.4.8.5 Market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- 8.5 Europe
- 8.5.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.5.2 Market estimates and forecasts, by ingredient, 2017 - 2030 (USD Million)
- 8.5.3 Market estimates and forecasts, by product, 2017 - 2030 (USD Million)
- 8.5.4 Market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- 8.5.5 Market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- 8.5.6 Germany
- 8.5.6.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.5.6.2 Market estimates and forecasts, by ingredient, 2017 - 2030 (USD Million)
- 8.5.6.3 Market estimates and forecasts, by product, 2017 - 2030 (USD Million)
- 8.5.6.4 Market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- 8.5.6.5 Market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- 8.5.7 U.K.
- 8.5.7.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.5.7.2 Market estimates and forecasts, by ingredient, 2017 - 2030 (USD Million)
- 8.5.7.3 Market estimates and forecasts, by product, 2017 - 2030 (USD Million)
- 8.5.7.4 Market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- 8.5.7.5 Market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- 8.5.8 Italy
- 8.5.8.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.5.8.2 Market estimates and forecasts, by ingredient, 2017 - 2030 (USD Million)
- 8.5.8.3 Market estimates and forecasts, by product, 2017 - 2030 (USD Million)
- 8.5.8.4 Market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- 8.5.8.5 Market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- 8.5.9 France
- 8.5.9.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.5.9.2 Market estimates and forecasts, by ingredient, 2017 - 2030 (USD Million)
- 8.5.9.3 Market estimates and forecasts, by product, 2017 - 2030 (USD Million)
- 8.5.9.4 Market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- 8.5.9.5 Market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- 8.6 Asia Pacific
- 8.6.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.6.2 Market estimates and forecasts, by ingredient, 2017 - 2030 (USD Million)
- 8.6.3 Market estimates and forecasts, by product, 2017 - 2030 (USD Million)
- 8.6.4 Market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- 8.6.5 Market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- 8.6.6 China
- 8.6.6.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.6.6.2 Market estimates and forecasts, by ingredient, 2017 - 2030 (USD Million)
- 8.6.6.3 Market estimates and forecasts, by product, 2017 - 2030 (USD Million)
- 8.6.6.4 Market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- 8.6.6.5 Market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- 8.6.7 Japan
- 8.6.7.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.6.7.2 Market estimates and forecasts, by ingredient, 2017 - 2030 (USD Million)
- 8.6.7.3 Market estimates and forecasts, by product, 2017 - 2030 (USD Million)
- 8.6.7.4 Market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- 8.6.7.5 Market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- 8.6.8 India
- 8.6.8.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.6.8.2 Market estimates and forecasts, by ingredient, 2017 - 2030 (USD Million)
- 8.6.8.3 Market estimates and forecasts, by product, 2017 - 2030 (USD Million)
- 8.6.8.4 Market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- 8.6.8.5 Market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- 8.7 Central & South America
- 8.7.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.7.2 Market estimates and forecasts, by ingredient, 2017 - 2030 (USD Million)
- 8.7.3 Market estimates and forecasts, by product, 2017 - 2030 (USD Million)
- 8.7.4 Market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- 8.7.5 Market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- 8.7.6 Brazil
- 8.7.6.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.7.6.2 Market estimates and forecasts, by ingredient, 2017 - 2030 (USD Million)
- 8.7.6.3 Market estimates and forecasts, by product, 2017 - 2030 (USD Million)
- 8.7.6.4 Market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- 8.7.6.5 Market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- 8.7.7 Argentina
- 8.7.7.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.7.7.2 Market estimates and forecasts, by ingredient, 2017 - 2030 (USD Million)
- 8.7.7.3 Market estimates and forecasts, by product, 2017 - 2030 (USD Million)
- 8.7.7.4 Market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- 8.7.7.5 Market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- 8.8 Middle East & Africa
- 8.8.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.8.2 Market estimates and forecasts, by ingredient, 2017 - 2030 (USD Million)
- 8.8.3 Market estimates and forecasts, by product, 2017 - 2030 (USD Million)
- 8.8.4 Market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- 8.8.5 Market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- 8.8.6 South Africa
- 8.8.6.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.8.6.2 Market estimates and forecasts, by ingredient, 2017 - 2030 (USD Million)
- 8.8.6.3 Market estimates and forecasts, by product, 2017 - 2030 (USD Million)
- 8.8.6.4 Market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- 8.8.6.5 Market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- 8.8.7 Saudi Arabia
- 8.8.7.1 Market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.8.7.2 Market estimates and forecasts, by ingredient, 2017 - 2030 (USD Million)
- 8.8.7.3 Market estimates and forecasts, by product, 2017 - 2030 (USD Million)
- 8.8.7.4 Market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- 8.8.7.5 Market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Chapter 9 Competitive Landscape
- 9.1 Recent Developments and Impact Analysis, by Key Market Participants
- 9.2 Company Categorization
- 9.3 Company Market Positioning
- 9.4 Company Geographical Presence, Public/Private
- 9.5 Vendor Landscape
- 9.5.1 List of key distributors, channel partners & end-users
- 9.6 Market Differentiators
- 9.7 Competitive Dashboard Analysis (Private & Public)
- 9.8 Public Companies
- 9.8.1 Company Market Positioning Analysis
- 9.8.2 SWOT Analysis
- 9.9 Private Companies
- 9.9.1 List of key emerging companies/technology disruptors/innovators
- Chapter 10 Company Profiles
- 10.1 Fairhaven Health
- 10.1.1 Company Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Benchmarking
- 10.2 Coast Science
- 10.2.1 Company Overview
- 10.2.2 Product Benchmarking
- 10.3 Lenus Pharma GesmbH
- 10.3.1 Company Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Benchmarking
- 10.4 Active Bio Life Science GmbH
- 10.4.1 Company Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Benchmarking
- 10.5 Orthomol
- 10.5.1 Company Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Benchmarking
- 10.6 Exeltis USA, Inc.
- 10.6.1 Company Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Benchmarking
- 10.7 PregPrep LLC
- 10.7.1 Company Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Benchmarking
- 10.8 Bionova
- 10.8.1 Company Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Benchmarking
- 10.8.4 Strategic Initiatives
- 10.9 TTK HealthCare Ltd.
- 10.9.1 Company Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Benchmarking
- 10.10 Fertility Nutraceuticals LLC
- 10.10.1 Company Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Benchmarking
- 10.10.4 Strategic Initiatives
- 10.11 Vitabiotics Ltd.
- 10.11.1 Company Overview
- 10.11.2 Financial Performance
- 10.11.3 Product Benchmarking
- 10.11.4 Strategic Initiatives
- 10.12 extreme V, Inc.
- 10.12.1 Company Overview
- 10.12.2 Product Benchmarking
- 10.13 VH Nutrition LLC
- 10.13.1 Company Overview
- 10.13.2 Product Benchmarking
- 10.14 CellOxess LLC
- 10.14.1 Company Overview
- 10.14.2 Financial Performance
- 10.14.3 Product Benchmarking
- 10.15 Gonadosan
- 10.15.1 Company Overview
- 10.15.2 Financial Performance
- 10.15.3 Product Benchmarking
- 10.16 Amino Expert (Innovamed Ltd.)
- 10.16.1 Company Overview
- 10.16.2 Product Benchmarking
- 10.17 Babystart Ltd.
- 10.17.1 Company Overview
- 10.17.2 Product Benchmarking
- 10.18 Crown Nutraceuticals
- 10.18.1 Company Overview
- 10.18.2 Financial Performance
- 10.18.3 Product Benchmarking
- 10.19 Sal Nature
- 10.19.1 Company Overview
- 10.19.2 Product Benchmarking
- 10.19.3 Strategic Initiatives
- 10.20 YadTech
- 10.20.1 Company Overview
- 10.20.2 Product Benchmarking
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.